Image

An INtervention TO Improve MOBility of Older Hospitalized Patients

Recruiting
60 years of age
Both
Phase N/A

Powered by AI

Overview

Low mobility during an acute care hospitalization is very frequent, particularly among older patients, and associated with adverse outcomes, such as persistent functional decline, institutionalization and death. However, increasing hospital mobility remains challenging because of the multiple existing barriers.

The goal of this clinical trial is to test the effect of a multilevel intervention to increase hospital mobility, which addresses modifiable barriers and facilitators and does not require unavailable additional resources.

This study aims to answer whether this intervention can improve mobility and patient-relevant outcomes such as life-space mobility and functional status.

The multilevel intervention will target:

  1. The patients, who will receive an information booklet, a customizable diary, an exercise booklet and an iPad with access to the videos of the exercise booklet.
  2. The healthcare professionals (nursing staff and physicians) who will complete an e-learning, receive an oral presentation on the intervention, and receive a "mobility checklist" that reminds them of what they should assess daily regarding mobility.
  3. The hospital environment, where posters will be hung in the wards, including walking itineraries, on topics of interest to older adults.

In a first phase, the intervention will be pilot-tested in one ward of each hospital. The intervention will then be adapted based on patient and healthcare professional feedback.

In a second phase, the intervention will be tested in a cluster randomized controlled trial, and compared to standard of care.

Eligibility

Inclusion criteria:

  • Admission to a general internal medicine (GIM) ward of a participating hospital
  • Age ≥60 years
  • Being ambulatory during the 2 weeks before admission (self-report)
  • Living in the community (not in a nursing home or another institution) for at least the last 30 days prior to admission
  • Ability to understand French or German
  • Planned length of stay at least 3 days after enrollment
  • For the pilot-study only: Possibility to start the study within 48 hours after admission to the GIM ward

Exclusion criteria:

  • Medical contraindication to walk (e.g., wound not allowing loading weight)
  • Wheelchair-bound
  • End-of-life
  • Severe psychiatric disorder (severe depression, schizophrenia, psychosis)
  • Delirium (according to the Confusion Assessment Method [CAM])

Additional exclusion criterion for the pilot-study only:

  • Dementia (defined as Mini-Cog <3)

Additional exclusion criteria for the RCT only:

  • Cognitive impairment making impossible to use study material (=implement the intervention) and to understand and sign informed consent, based on clinical judgement, except if a proxy can be actively involved in the study and provides consent
  • Severe visual impairment

Study details

Hospital Mobility, Mobility Limitation, Life-Space, Functional Status, Hospital-Acquired Condition

NCT05639231

Insel Gruppe AG, University Hospital Bern

14 April 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.